&beta;-cell dysfunction: Its critical role in prevention and management of type 2 diabetes

doi:10.4239/wjd.v6.i1.109

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (17002)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series, Tables (1-1) series.

Item

Count

PDF

1049

WORD

391

HTML

9538

Figures (1-10)

382

Tables (1-1)

246

Sum=11606

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

864

Download

1957

Sum=2821

Publishing Process of This Article

Item

Count

Browse

1106

Download

1469

Sum=2575

Feb 15, 2015 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (175)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Feb 15, 2015; 6(1): 109-124
Published online Feb 15, 2015. doi: 10.4239/wjd.v6.i1.109

Full Size Figure Download Figure

Figure 3 β-cell mass in patients with normal glucose tolerance, impaired fasting glycemia and type 2 diabetes. Adapted and modified from the study by Butler et al[12]. NGT: Normal glucose tolerance; IFG: Impaired fasting glycemia; T2DM: Type 2 diabetes.

Citation: Saisho Y. β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes. World J Diabetes 2015; 6(1): 109-124
URL: https://www.wjgnet.com/1948-9358/full/v6/i1/109.htm
DOI: https://dx.doi.org/10.4239/wjd.v6.i1.109